產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CCDC134抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CCDC134抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CCDC134
Cat. Number:
Anti-CCDC134抗體KL-8079R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Chromosome 22 containsAnti-CCDC134抗體 over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. CCDC134 (coiled-coil domain containing 134), also known as MGC21013 or FLJ22349, is a 229 amino acid protein encoded by a gene mapping to human chromosome 22.
Also known as:
CC134_HUMAN; ccdc134;Anti-CCDC134抗體 coiled-coil domain containing 134; Coiled-coil domain-containing protein 134; dJ821D11.3; FLJ22349; MGC21013.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CCDC134.
●
Predicted Molecular Weight: 24kDa.
Storage:
Shipped at 4℃, Store Anti-CCDC134抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-CCDC134抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-CCDC134抗體 must be determined by the end user.
kl141Hu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Mu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Ra01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Si01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Hu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Mu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Rb51 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl143Ca01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Eq01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ga01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Po01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl144Bo01 血管內(nèi)皮生長(zhǎng)因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Bo01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl146Bo01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl147Bo01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Ga01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Hu01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
